Severe forms of scabies (crusted scabies and profuse scabies) require a specific treatment. Ivermectin is a recommended treatment in common forms of scabies and represents a promising treatment in crusted scabies in case reports. However, response to ivermectin remains variable among studies, and there is no consensus on the schemes to adopt (dosages and administrations). Ivermectin at 400 µg/kg has already been used, without showing toxicity (in head lice treatment in particular). Investigators propose to demonstrate that 400µg/kg ivermectin dosage will show better efficacy than a 200µg/kg in patients with severe forms of scabies (crusted and profuse).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
133
Oral ivermectin 200 µg/kg three times (D0, D7 and D14) + topical treatment (permethrin 5% cream) on skin, hair and genital organs (D0 and D7) + emollient cream (Dexeryl® or other) daily on skin (D0 to D28)
Oral ivermectin 400 µg/kg three times (D0, D7 and D14) + topical treatment (permethrin 5% cream) on skin, hair and genital organs (D0 and D7) + emollient cream (Dexeryl® or other)daily on skin (D0 to D28)
Henri Mondor Hospital
Créteil, France
Rate of a successful treatment defined by : -Two negative parasitologic and/or two dermoscopic exams
Parasitologic and/or dermoscopic exams will be perform at days 18 +/-2days and at days 21+/-2 days
Time frame: Days 21+/-2 days
Rate of a successful treatment defined by : - A clinical response : disappearance of clinical active lesions
Time frame: Days 28+/- 2 days
Rate of adverse effects
Time frame: Days 18 +/-2 days, Days 21+/-2 days and Days 28+/-2 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.